Clinical trial
Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic…
NCT00411333 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00411333 |
|---|---|
| Title | Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy |
| Official title | Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | triamcinolone acetonide (Kenalog) |
| Enrollment | 100 |
| Start date | Jul 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Dec 14, 2006 |
| Last update posted | Nov 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: